Sep 30

Scientific

SS 48 - Beyond Tumor Control: Quality of Life and Toxicity in Prostate RT

09:00am - 10:15am ET

Genitourinary Cancer

MODERATOR(S)

Adam Olson, MD, MS - UPMC Hillman Cancer Center

Jay Shiao, MD, MS, MPH - University of Colorado Cancer Center

Credits

AMA PRA Category 1 Credits:

1.25

Rate This Session

Presentations

09:00am - 09:10am ET

Primary Endpoint Analysis of a Multi-Center Phase II Randomized Control Trial of Neurovascular-Sparing SAbR in Localized Prostate Cancer (Late Breaking Abstract)

Speaker: Neil Desai, MD - University of Texas Southwestern Medical Center, Dallas
09:10am - 09:20am ET

International Consensus Guideline on Management of Genitourinary Adverse Events Associated with Prostate Cancer Radiation Therapy

Speaker: Anna Dornisch, MD - UC San Diego, La Jolla
09:20am - 09:30am ET

Segmental Internal Pudendal Artery Dose-Volume Parameters as a Novel Predictor of Long-Term Sexual Function after Prostate Radiation Therapy with and without a Hydrogel Spacer

Speaker: Omar Awad, MD, MS - Baylor College of Medicine, Houston
09:30am - 09:40am ET

Effectiveness and Safety of Pre-formed Radiopaque Hydrogel for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy: Preliminary Results of a Multicenter RCT (HYDROSPACE)

Speaker: Brian Baumann, MD - Springfield Clinic, Springfield
09:40am - 09:50am ET

Relugolix vs. Leuprolide in Combination with Radiotherapy for Localized Prostate Cancer: Analysis of Patient-Reported Quality of Life in a Randomized Trial

Speaker: Nikhil Sebastian, MD - Emory University Winship Cancer Institute, Atlanta
09:50am - 10:00am ET

Stereotactic Radiotherapy vs. Stereotactic Boost for Prostate Cancer: 2-year Toxicity and Quality of Life from a Randomized Controlled Trial (TROG 1801 NINJA)

Speaker: Jarad Martin, MB, ChB, PhD, DMed(Research) BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle
10:00am - 10:10am ET

Discussant

Speaker: Amar Kishan, MD - UCLA, Culver City